Skip to NavigationSkip to content

Pharmafile - Medical Communications

top 10
COVID-19 news has slowed down in the last week, allowing different pharma developments to take centre stage. In the last seven days, the FDA has put...
GSK building
GlaxoSmithKline’s (GSK) Phase II OSCAR study of their otilimab antibody’s effect on COVID-19 patients has shown promising results in older people,...
NICE has recommended Novartis’ Kisqali (ribociclib) in combination with fulvestrant for women with prior endocrine therapy.
MSD, known as Merck in the United States and Canada, has announced that it will acquire clinical-stage biotechnology company Pandion Therapeutics...

Features

Early and managed access programmes provide opportunities for patients to get the treatments they need faster - but the COVID-19 pandemic has...

Appointments

AI-driven pharma-tech company Exscientia has appointed Elizabeth Crain to their Board of Directors.

She will use her new position to chair...

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches